VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 363 filers reported holding VANECK VECTORS ETF TR in Q4 2016. The put-call ratio across all filers is 0.93 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $940,911 | +6.5% | 27,731 | -0.7% | 0.23% | +5.1% |
Q1 2024 | $883,177 | +0.9% | 27,931 | -1.1% | 0.22% | -10.7% |
Q4 2023 | $875,442 | +11.2% | 28,231 | -3.5% | 0.24% | +5.7% |
Q3 2023 | $787,524 | -17.9% | 29,265 | -8.1% | 0.23% | -18.7% |
Q2 2023 | $958,711 | -9.3% | 31,840 | -2.6% | 0.28% | -14.2% |
Q1 2023 | $1,057,432 | +10.8% | 32,687 | -1.8% | 0.33% | +2.2% |
Q4 2022 | $954,012 | +20.0% | 33,287 | +1.0% | 0.32% | +9.5% |
Q3 2022 | $795,000 | -16.8% | 32,948 | -5.6% | 0.30% | -9.5% |
Q2 2022 | $956,000 | -28.6% | 34,900 | 0.0% | 0.33% | -18.1% |
Q1 2022 | $1,338,000 | +36.1% | 34,900 | +13.7% | 0.40% | +48.0% |
Q4 2021 | $983,000 | +10.1% | 30,700 | +1.3% | 0.27% | +26.3% |
Q3 2021 | $893,000 | -16.0% | 30,297 | -3.2% | 0.21% | -13.1% |
Q2 2021 | $1,063,000 | +265.3% | 31,297 | +249.6% | 0.24% | +245.1% |
Q1 2021 | $291,000 | -9.6% | 8,952 | 0.0% | 0.07% | -16.5% |
Q4 2020 | $322,000 | -6.1% | 8,952 | +2.3% | 0.08% | -16.7% |
Q3 2020 | $343,000 | -14.5% | 8,750 | -19.9% | 0.10% | -22.1% |
Q2 2020 | $401,000 | +91.0% | 10,930 | +19.7% | 0.13% | +65.8% |
Q1 2020 | $210,000 | -24.7% | 9,130 | -4.2% | 0.08% | -19.4% |
Q4 2019 | $279,000 | +4.1% | 9,530 | -5.2% | 0.10% | +14.0% |
Q3 2019 | $268,000 | -19.0% | 10,050 | -22.4% | 0.09% | -17.3% |
Q2 2019 | $331,000 | +7.8% | 12,950 | -5.5% | 0.10% | +19.5% |
Q1 2019 | $307,000 | +5.5% | 13,700 | -0.7% | 0.09% | -21.6% |
Q4 2018 | $291,000 | +13.7% | 13,800 | 0.0% | 0.11% | +27.6% |
Q3 2018 | $256,000 | -16.9% | 13,800 | 0.0% | 0.09% | -26.9% |
Q2 2018 | $308,000 | +1.7% | 13,800 | 0.0% | 0.12% | -0.8% |
Q1 2018 | $303,000 | -5.6% | 13,800 | 0.0% | 0.12% | -9.1% |
Q4 2017 | $321,000 | +24.9% | 13,800 | +23.2% | 0.13% | +29.4% |
Q3 2017 | $257,000 | -17.4% | 11,200 | -20.6% | 0.10% | -16.4% |
Q2 2017 | $311,000 | -8.5% | 14,100 | -5.4% | 0.12% | -12.9% |
Q1 2017 | $340,000 | +21.4% | 14,900 | +11.2% | 0.14% | +20.7% |
Q4 2016 | $280,000 | – | 13,400 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |